These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 35491201)
41. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation. Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559 [TBL] [Abstract][Full Text] [Related]
42. Non-Fasting Hypertriglyceridemia as an Independent Risk Factor for Coronary In-Stent Restenosis after Primary Bare Metal Stent Implantation in Patients with Coronary Artery Disease. Yoshimura M; Umemoto S; Kawano R; Hiromoto M; Yamada M; Fujimura T; Tanaka M; Nao T; Miura T; Yano M Int Heart J; 2021; 62(5):970-979. PubMed ID: 34588411 [TBL] [Abstract][Full Text] [Related]
43. A comparison of procedural success rate and long-term clinical outcomes between in-stent restenosis chronic total occlusion and de novo chronic total occlusion using multicenter registry data. Lee SH; Cho JY; Kim JS; Lee HJ; Yang JH; Park JH; Hong SJ; Choi RK; Choi SH; Gwon HC; Lim DS; Yu CW Clin Res Cardiol; 2020 May; 109(5):628-637. PubMed ID: 31552494 [TBL] [Abstract][Full Text] [Related]
44. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry. Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528 [TBL] [Abstract][Full Text] [Related]
45. Efficacy of drug-coated balloon angioplasty in early versus late occurring drug-eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials. Koch T; Cassese S; Xhepa E; Mayer K; Tölg R; Hoppmann P; Laugwitz KL; Byrne RA; Kastrati A; Kufner S Catheter Cardiovasc Interv; 2020 Nov; 96(5):1008-1015. PubMed ID: 31789486 [TBL] [Abstract][Full Text] [Related]
46. New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent. Wang JL; Qin Z; Wang ZJ; Shi DM; Liu YY; Zhao YX; Yang LX; Cheng WJ; Zhou YJ J Geriatr Cardiol; 2018 Feb; 15(2):137-145. PubMed ID: 29662507 [TBL] [Abstract][Full Text] [Related]
47. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents. Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ; Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097 [TBL] [Abstract][Full Text] [Related]
48. Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis. Xu B; Qian J; Ge J; Wang J; Chen F; Chen J; Wei M; Chen Y; Yang Y; Gao R; Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():624-9. PubMed ID: 26775079 [TBL] [Abstract][Full Text] [Related]
49. A Randomized Comparison of Paclitaxel-Eluting Balloon Versus Everolimus-Eluting Stent for the Treatment of Any In-Stent Restenosis: The DARE Trial. Baan J; Claessen BE; Dijk KB; Vendrik J; van der Schaaf RJ; Meuwissen M; van Royen N; Gosselink ATM; van Wely MH; Dirkali A; Arkenbout EK; de Winter RJ; Koch KT; Sjauw KD; Beijk MA; Vis MM; Wykrzykowska JJ; Piek JJ; Tijssen JGP; Henriques JPS JACC Cardiovasc Interv; 2018 Feb; 11(3):275-283. PubMed ID: 29413242 [TBL] [Abstract][Full Text] [Related]
50. Risk prediction of in-stent restenosis among patients with coronary drug-eluting stents: current clinical approaches and challenges. Sakamoto A; Sato Y; Kawakami R; Cornelissen A; Mori M; Kawai K; Fernandez R; Fuller D; Gadhoke N; Guo L; Romero ME; Kolodgie FD; Virmani R; Finn AV Expert Rev Cardiovasc Ther; 2021 Sep; 19(9):801-816. PubMed ID: 33470872 [No Abstract] [Full Text] [Related]
51. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents. Alfonso F; Pérez-Vizcayno MJ; Cuesta J; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Cequier A; Velázquez M; Moreno R; Mainar V; Domínguez A; Moris C; Molina E; Rivero F; Jiménez-Quevedo P; Gonzalo N; Fernández-Pérez C; JACC Cardiovasc Interv; 2018 May; 11(10):981-991. PubMed ID: 29798776 [TBL] [Abstract][Full Text] [Related]
52. Treatment effect of metformin combined with atorvastatin in reducing in-stent restenosis after percutaneous coronary intervention in coronary artery disease patients with type 2 diabetic patients. Chen M; Ma F; Su B; Wang C; Zheng Q; Zhang Y; Li M; Liu S; Zhang S; Yuan L Medicine (Baltimore); 2022 Oct; 101(41):e31107. PubMed ID: 36254086 [TBL] [Abstract][Full Text] [Related]
53. CHA Zhao SG; Xu JJ; Tao ZH; Jin L; Liu Q; Zheng WY; Jiang LQ; Wang NF J Int Med Res; 2019 Jun; 47(6):2533-2544. PubMed ID: 31039653 [TBL] [Abstract][Full Text] [Related]
54. Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and health-economic evaluation. Zbinden R; von Felten S; Wein B; Tueller D; Kurz DJ; Reho I; Galatius S; Alber H; Conen D; Pfisterer M; Kaiser C; Eberli FR Cardiovasc Ther; 2017 Feb; 35(1):19-25. PubMed ID: 27662632 [TBL] [Abstract][Full Text] [Related]
55. Same or Different Drug-Eluting Stent Re-Implantation for Drug-Eluting Stent Restenosis: An Assessment Including Second-Generation Drug-Eluting Stents. Yabe T; Toda M; Nakanishi R; Saito D; Watanabe I; Okubo R; Amano H; Ikeda T J Interv Cardiol; 2016 Jun; 29(3):311-8. PubMed ID: 27245125 [TBL] [Abstract][Full Text] [Related]
56. Long-Term Clinical Outcomes after Treatment with Excimer Laser Coronary Atherectomy for In-Stent Restenosis of Drug-Eluting Stent. Ichimoto E; Kadohira T; Nakayama T; De Gregorio J Int Heart J; 2018 Jan; 59(1):14-20. PubMed ID: 29332914 [TBL] [Abstract][Full Text] [Related]
57. Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis. Drozd J; Wójcik J; Małek R; Korona B; Zapolski T; Wysokiński A Kardiol Pol; 2010 Jun; 68(6):637-45. PubMed ID: 20806192 [TBL] [Abstract][Full Text] [Related]
58. Angiographic patterns of restenosis after percutaneous intervention of chronic total occlusive lesions with drug-eluting stents. Lee SP; Shin DH; Park KW; Kang HJ; Koo BK; Cho YS; Yeon TJ; Chae IH; Choi DJ; Kim HS Int J Cardiol; 2012 Apr; 156(2):180-5. PubMed ID: 21109317 [TBL] [Abstract][Full Text] [Related]
59. Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis. Giacoppo D; Alfonso F; Xu B; Claessen BEPM; Adriaenssens T; Jensen C; Pérez-Vizcayno MJ; Kang DY; Degenhardt R; Pleva L; Baan J; Cuesta J; Park DW; Kukla P; Jiménez-Quevedo P; Unverdorben M; Gao R; Naber CK; Park SJ; Henriques JPS; Kastrati A; Byrne RA J Am Coll Cardiol; 2020 Jun; 75(21):2664-2678. PubMed ID: 32466881 [TBL] [Abstract][Full Text] [Related]
60. Coronary Intravascular Brachytherapy for Recurrent Coronary Drug-Eluting Stent In-Stent Restenosis: A Systematic Review and Meta-Analysis. Megaly M; Glogoza M; Xenogiannis I; Vemmou E; Nikolakopoulos I; Omer M; Saad M; Willson L; Monyak DJ; Sullivan P; Pershad A; Chavez I; Mooney M; Traverse J; Wang Y; Garcia S; Poulose A; Burke MN; Brilakis ES Cardiovasc Revasc Med; 2021 Feb; 23():28-35. PubMed ID: 32883584 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]